Skip to main content
. 2019 Jan 25;55(1):47–53. doi: 10.4068/cmj.2019.55.1.47

FIG. 2. Inappropriate treatment according to GOLD guideline published in 2017. GOLD: Global initiative for chronic obstructive lung disease, BD: bronchodilator, LABA: long acting beta2 agonist, ICS: inhaled corticosteroids, LAMA: long acting anticholinergics.

FIG. 2